news

Stress impact on protein particle formation for monoclonal antibody formulation

1
SHARES

The driving factor for protein particle formation is surface mediated in protein only formulations in manufacturing, research asserts.

particle formation dilatational stress

A study has determined that for biologics subject to multiple stresses during bioprocessing and manufacturing, “exposure to air-liquid interfacial dilatational stress is the predominant mechanism impacting protein particle formation, [both] at the interface and in the bulk solution”.

 

ACCESS your FREE COPY

 


This report addresses the key factors shaping pharmaceutical formulation, including regulation, QC and analysis.

Access the full report now to discover the techniques, tools and innovations that are transforming pharmaceutical formulation, and learn how to position your organisation for long-term success.

What you’ll discover:

  • Key trends shaping the pharmaceutical formulation sector
  • Innovations leading progress in pharmaceutical formulation and how senior professionals can harness their benefits
  • Considerations and best practices when utilising QbD during formulation of oral solid dosage forms
  • And more!

Don’t miss your chance to access this exclusive report ! Access now – it’s free

Researchers established a “unique” set-up using a peristaltic pump and a Langmuir-Pockels trough to study the impact of hydrodynamic shear stress due to pumping and interfacial dilatational stress, on the formation protein particles.

The set-up was tested on an “industrially relevant [immunoglobulin G] (IgG) [monoclonal antibody] (mAb) solution.” Formation under different stress conditions was characterised using microflow and brightfield imaging.

Impact of dilatational stress on particle formation

Protein solutions “exposed to interfacial dilatational stress acting at the air-water interface have the highest protein particle concentrations”, according to the paper. This was found to be the case “regardless of the solution being pumped prior to application of compression/expansion stress at the interface”.

The researchers concluded that the order in which the protein solution is subjected to hydrodynamic shear and interfacial dilatational forces are applied, “does in fact have a significant impact on [formation of the particles], both at the interface and in the bulk solution”.

Based on the experiments performed, interfacial properties of the protein film were not impacted by pumping. This was established based on “protein solutions subjected to various combinations of stress…surface pressure values during adsorption and when subjected to compression/dilatational stresses showed no change”.

[these findings] increase our understanding of the underlying mechanisms dominating surface-mediated and bulk-mediated protein particle formation during bioprocessing and manufacturing”

Polysorbate 80 (PS80) prevented surface mediated particle formation and vastly decreased the formation under all stress conditions, the paper reported. According to the authors, this provides “further evidence that the driving factor for protein particle formation is surface mediated in protein only formulations”.

An additional finding was that protein particles formed due to interfacial dilatational stress “can be correlated to protein particle formation during mechanical shaking”.

Griffin et al. concluded that the studies highlighted in the paper “increase our understanding of the underlying mechanisms dominating surface-mediated and bulk-mediated protein particle formation during bioprocessing and manufacturing”.

The paper was published in the Journal of Pharmaceutical Sciences

Share via
Share via